QuantOn Cal® is a Health Canada Licensed device that combines the use of an immunological rapid test with a smartphone app to quantify the inflammatory marker calprotectin in stool samples. The test system is designed for self-testing by patients with inflammatory bowel disease (IBD) under the care of a healthcare practitioner.
QuantOn Cal® Rapid Test
Sample Type (Matrix): Stool
Incubation time: 15 minutes
Size: 1 self-test
Regulatory Status: For Research Use Only in the U.S.
The results attained from QuantOn Cal® can help assess inflammatory activity within the intestines of IBD patients. The test system consists of an immunological rapid test that detects human calprotectin via gold-conjugated anti-calprotectin antibodies and a smartphone app that analyzes results quantitatively. Your patients’ results are sent to you automatically following sample analysis, allowing you to examine inflammatory activity and modify therapy if necessary.
Learn more about Preventis rapid self-tests.
The QuantOn Cal® Rapid Test was developed by Preventis GmbH.
This is the RUO version of the QuantOn Cal® Rapid Test (Item number KST11002EP04).
|Dimensions||5 × 5 × 4 in|